 |
Trials |
A Multi-Center, Open-Label, Phase II Study of Ipilimumab (MDX-010)Extended-Treatment Monotherapy or Follow-up for Patients Previously Enrolled in Ipilimumab (MDX-010) ProtocolsCancer type: Melanoma Phase: II Principal Investigator: Aamdal Steinar Country: NO Keywords: Norway, Oslo University Hospital Status: Completed Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT00162123?term=CA184-025&rank=1 |